Cargando…
Serum CCL2 Is a Prognostic Biomarker for Non-Metastatic Castration-Sensitive Prostate Cancer
Purpose: Prostate-specific antigen (PSA) is a useful prostate cancer (PC) biomarker, but some cases reported that PSA does not correlate with the Gleason score. Serum chemokine (CC motif) ligand 2 (CCL2) has been reported to be a potential complementary PSA biomarker, but it remains unclear whether...
Autores principales: | Iwamoto, Hiroaki, Izumi, Kouji, Nakagawa, Ryunosuke, Toriumi, Ren, Aoyama, Shuhei, Kamijima, Taiki, Shimada, Takafumi, Kano, Hiroshi, Makino, Tomoyuki, Naito, Renato, Kadomoto, Suguru, Yaegashi, Hiroshi, Kawaguchi, Shohei, Nohara, Takahiro, Shigehara, Kazuyoshi, Kadono, Yoshifumi, Mizokami, Atsushi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9598117/ https://www.ncbi.nlm.nih.gov/pubmed/36289628 http://dx.doi.org/10.3390/biomedicines10102369 |
Ejemplares similares
-
Suppression of androgen receptor signaling induces prostate cancer migration via activation of the CCL20–CCR6 axis
por: Kano, Hiroshi, et al.
Publicado: (2022) -
A novel screening strategy for clinically significant prostate cancer in elderly men over 75 years of age
por: Iwamoto, Hiroaki, et al.
Publicado: (2020) -
Decreased febrile neutropenia during inpatient chemotherapy for urologic cancer during coronavirus disease 2019 pandemic
por: Toriumi, Ren, et al.
Publicado: (2022) -
Testosterone Replacement Therapy for Patients with Hypogonadism after High Dose-Rate Brachytherapy for High-Risk Prostate Cancer: A Report of Six Cases and Literature Review
por: Kadomoto, Suguru, et al.
Publicado: (2020) -
Analysis of the Safety of Pegfilgrastim Addition in Bleomycin, Etoposide, and Cisplatin Treatment Patients With Germ Cell Tumors
por: Nakagawa, Ryunosuke, et al.
Publicado: (2022)